Mariana Uchôa Email

Principal Scientist . Karma Biotechnologies

Current Roles

Employees:
16
Revenue:
$2.5M
About
Therapies for autoimmune diseases are stuck in the 20th century – physicians can only alleviate a patient's symptoms by crippling their entire immune system. Karma was founded by a team of immune engineers, nanotech scientists, and company builders to create a better solution. We're developing Xavines™, off-the-shelf therapeutics designed to shut down only the self-attacking rogue immune cells while leaving the rest of the immune system functional.
Karma Biotechnologies Address
1900 E 7th Pl
Los Angeles, CA
United States
Karma Biotechnologies Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.